Price target
3,669.530.000.00%
The 16 analysts offering 1 year price forecasts for JAZZ/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to JAZZ/N in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
JAZZ/N EPS for the last quarter is 34.42 MXN despite the estimation of 95.42 MXN. In the next quarter EPS is expected to reach −124.94 MXN. Track more of JAZZ PHARMACEUTICALS PLC financials and stay on top of what is up with the company.
In the next quarter JAZZ PHARMACEUTICALS PLC revenue is expected to reach 20.52 B MXN. Check out JAZZ PHARMACEUTICALS PLC revenue and earnings and make informed decisions.
According to analysts, JAZZ/N price target is 3,669.53 MXN with a max estimate of 4,433.31 MXN and a min estimate of 2,833.46 MXN. Check if this forecast comes true in a year, meanwhile watch JAZZ PHARMACEUTICALS PLC stock price chart and keep track of the current situation with JAZZ/N news and stock market news.
We've gathered opinions of 19 analysts rating JAZZ/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.